期刊论文详细信息
Early Structural Valve Deterioration of Mitroflow Aortic Bioprosthesis Mode, Incidence, and Impact on Outcome in a Large Cohort of Patients
Article
关键词: PERICARDIAL BIOPROSTHESIS;    CARPENTIER-EDWARDS;    HEART-VALVE;    FOLLOW-UP;    ELDERLY-PATIENTS;    REPLACEMENT;    DEGENERATION;    STENOSIS;    EXPERIENCE;    PROSTHESES;   
DOI  :  10.1161/CIRCULATIONAHA.114.010400
来源: SCIE
【 摘 要 】

Background-Structural valve deterioration (SVD) is a major flaw of bioprostheses. Early SVD has been suspected in the last models of Mitroflow bioprosthesis. We sought to assess the incidence, mode, and impact of SVD on outcome in a large series of Mitroflow aortic valve replacement. Methods and Results-Six hundred seventeenconsecutive patients (aged 76.1 +/- 6.3 years) underwent aortic valve replacement with a Mitroflow prosthesis (models 12A/LX) between 2002 and 2007. By echocardiography, 39 patients developed early SVD (1.66% per patient-year), with stenosis as the main mode (n=36). Mean delay to SVD was only 3.8 +/- 1.4 years, and 5-year SVD-free survival was 91.6% (95% confidence interval [CI], 88.7-94.7) for the whole cohort and 79.8% (95% CI, 71.2-89.4) and 94.0% (95% CI, 90.3-97.8) for 19- and 21-mm sizes, respectively. Among the 39 patients with SVD, 13 patients (33%) had an accelerated SVD once the mean gradient exceeded 30 mm Hg. Valve-related death was 46.2% in this SVD subgroup. Five-year overall survival was 69.6% (95% CI, 65.7-73.9). In multivariable analysis, SVD was the strongest correlate of overall mortality (hazard ratio=7.7; 95% CI, 4.4-13.6). Conclusions-Early SVD is frequent in Mitroflow bioprosthesis (models 12A/LX), especially for small sizes (19 and 21 mm), and reduces overall survival. An unpredictable accelerated pattern of SVD constitutes a life-threatening condition. In view of the large number of Mitroflow valves implanted worldwide, one can expect an epidemic of SVD and valve-related deaths, which represents a major public health issue, especially in the elderly. Hence, a close follow-up with yearly echocardiography after Mitroflow implantation is advisable. An urgent reoperation should be discussed in patients with severe SVD even though they are still asymptomatic.

【 授权许可】

Free   

  文献评价指标  
  下载次数:0次 浏览次数:4次